R. Sainsbury

发表

Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer.

A. Hackshaw, M. Baum, M. Roughton, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study.

A. Hackshaw, M. Baum, B. Nordenskjöld, 2006, European journal of cancer.

Implementation of a short‐stay programme after breast cancer surgery (Br J Surg 2010; 97: 189–194)

D. Rew, G. Royle, G. Royle, 2010, The British journal of surgery.

Beneficial side-effect profile of anastrozole compared with tamoxifen confirmed by additional 7 months of exposure data: a safety update from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial

R. Sainsbury, 2002 .

Progress in the management of solid tumours Breast cancer

Colin D. Johnson, R. Sainsbury, 2008 .

Pregnancy‐associated plasma protein A regulates mitosis and is epigenetically silenced in breast cancer

K. Stoeber, S. Apostolidou, M. Widschwendter, 2014, The Journal of pathology.

High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics.

M. Schnall, A. Lokshin, J. Tomaszewski, 2006, Journal of proteome research.

Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.

Richard Sainsbury, Kai Stoeber, Mohammed Rashid, 2010, The American journal of pathology.

Have the Organisms that Cause Breast Abscess Changed With Time?––Implications for Appropriate Antibiotic Usage in Primary and Secondary Care

M. Chand, A. Pallett, N. Dabbas, 2010, The breast journal.

Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer

M Loddo, K Stoeber, G. Williams, 2009, British Journal of Cancer.

Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53 mutant Her2 and triple negative breast cancer

G. Williams, K. Stoeber, I. Proctor, 2010, Breast Cancer Research.

DNA replication licensing and cell cycle kinetics of normal and neoplastic breast

G. Williams, K. Stoeber, T. Fanshawe, 2005, British Journal of Cancer.

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

M. Dowsett, J. Farndon, J. Salter, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

J Cuzick, L Ambroisine, J. Cuzick, 2007, The Lancet.

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer

A. Hackshaw, M. Baum, T. Fornander, 2009, Journal of the National Cancer Institute.

Macrophage infiltration of breast tumours: a prospective study.

I. Lauder, W. Aherne, J. Stewart, 1977, Journal of clinical pathology.

Promise of multiphoton detection in discovery and diagnostic proteomics

C. Mulvey, J. Godovac-Zimmermann, R. Sainsbury, 2007, Expert review of proteomics.

Epidermal growth factor receptors

A. Harris, R. Sainsbury, T. Cooke, 1985 .

Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients.

M. Dowsett, F. Cohen, P. Veronesi, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Epidermal growth factor receptor and other oncogenes as prognostic markers.

A. Harris, A L Harris, S Nicholson, 1992, Journal of the National Cancer Institute. Monographs.

Anastrozole is superior to tamoxifen in the treatment of postmenopausal women with early breast cancer - first results of the ATAC ('Arimidex', Tamoxifen, alone or in combination) trial

R. Sainsbury, 2002 .

Ultra-sensitive immunoassays using multi-photon-detection in diagnostic proteomics of blood.

J. Tomaszewski, J. Godovac-Zimmermann, A. Drukier, 2005, Journal of proteome research.

Influence of clinician workload and patterns of treatment on survival from breast cancer

C. Round, R. Sainsbury, R. Haward, 1995, The Lancet.

Surgeon workload and survival from breast cancer

D. Forman, R. Sainsbury, R. Haward, 2003, British Journal of Cancer.

Variability in the elimination of mianserin in elderly patients.

R. Sainsbury, E. Begg, D. Clark, 1989, British journal of clinical pharmacology.

Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer

M. Falzon, R. Sainsbury, M. Keshtgar, 2006, The British journal of surgery.